DT
HealthMore in Health→
Weight Loss Drug Tied to Lower Eye Disease Risk in Diabetics
Key Takeaways
- A large-scale study finds GLP-1 receptor agonist users have significantly lower risk of diabetic retinopathy and eye complications
- The findings add eye health to a growing list of benefits including cardiovascular and renal protection from these drugs
- Diabetic retinopathy is the leading cause of blindness among working-age adults, affecting one-third of diabetes patients
DE
DT Editorial Team··5 min read·via medicalxpress.com